Funds

Hubei Tong Ying
Equity Investment Fund II
Partnership
(Limited Partnership)

• Formed on Nov. 11, 2022

Supporting business innovations in China's healthcare and consumer fields

We have formed this fund with Jointown Pharmaceutical Group, the largest private pharmaceutical distributor in China. There are emerging consumer and logistics trends in China as well as business innovations in the medical and healthcare industries facing the aging population and the post-COVID-19 era. With the support from the Hubei provincial government, the local team and we will invest in companies with high growth potential.

DCI Venture
Growth Investment
Limited Partnership II

• Formed on Jan. 1, 2023

Accelerating growth of impactful Japanese startups

There is an increasing concern regarding Japan’s presence in the global economy due to the declining birthrate and aging population. On the other hand, exploration of frontiers in the space, energy, and medical fields is making constant progress. This fund invests in Japanese startups with high growth potential to accelerate their businesses in various fields in and outside of Japan.

Daiwa Taiwan-Japan
BioVenture Investment
Limited Partnership II

• Formed on Dec. 15, 2020

Promoting drug discovery businesses in Japan and Taiwan

Taiwan is rapidly becoming prominent in the drug discovery field. To create synergy between Japan, one of the industry leaders, and Taiwan, this fund invests in regenerative medicine and new drug candidates created with innovative technologies. This fund is also funding and providing hands-on support for the fund-led creation of startups, leveraging the fund’s human resources and expertise.

CECEP Hubei
SDG Industry
Equity Investment Fund
Limited Partnership

• Formed on Oct. 26, 2020

Promoting eco-friendly development of economy in China

The Yangtze River Economic Belt is estimated to occupy 40% of the population and economic activities in China and thus is of great importance in China’s efforts to protect the ecosystem. We have formed this fund with the local, strategic partners to invest in companies in the environmental, alternative energy, circular economy, and new material fields to improve their enterprise value and accelerate their social impact.

DAIWA-SSIAM
Vietnam
Growth Fund IV (USD) L.P.

• Formed on Aug. 11, 2025

Achieving both high growth and stable returns in Vietnam over a sustained medium-to long-term horizon

Achieving both high growth and stable returns in Vietnam over a sustained medium-to long-term horizon. Vietnam is entering a new phase of growth, driven by the expansion of the digital economy, the advancement of manufacturing capabilities, and increased infrastructure investment. As with Fund III, we will co-manage this fund in partnership with SSI Asset Management (SSIAM), the subsidiary of SSI Securities, Vietnam’s largest securities company. Through growth investments in private companies and PIPEs investments in listed companies, with a focus on sectors such as retail and consumer discretionary, manufacturing, healthcare, and infrastructure, we aim to achieve a balance of high growth and stable returns while generating enduring value over the medium to long term.

DAIWA-SSIAM
Vietnam
Growth Fund III L.P.

• Formed on Sep. 15, 2020

Investing in the lifestyle shift and economic growth in Vietnam

Industrialization and increase in middle-income families pulled up the income standard in Vietnam, subsequently changing people’s lifestyles. We operate this fund with the subsidiary of SSI, the largest securities corporation in Vietnam, to invest mainly in unlisted small to midsize Vietnamese companies in sectors that benefit from this new trend.